Global Nasal Spray Market Size & Share Projected to Reach USD 21.50 Billion By 2026

10-Jun-2021 | Facts and Factors

We at Facts And Factors have recently added a market study titled “Nasal Spray Market” to our plethora of market studies. We transcribed the market study with the goal of giving our readers a comprehensive read in order to give our readers a complete grasp of the market in terms of revenue, size, and volume. Furthermore, we estimate that the global Nasal Spray Market will grow from an initial value of USD 12 Billion in the year 2020 to a value of USD 21.50 Billion with a growth rate of 6.15% CAGR by 2026 over the forecast period 2021 ­2026.

Nasal sprays are used to treat and relieve patients suffering from allergies through the pathway of the nasal airway in order to provide comfort. However, with the recent growth of the market, the current application use case of the market is far stretched from its regular applications into hormone replacement therapy, treatment of Alzheimer’s and Parkinson’s, and migraines. The driving factors for the significant growth of the nasal spray market are the rise in infectious and allergy-based disorders among consumers and the proven efficacy of nasal-based drug delivery systems over their counterparts.

Additionally, the precision, low-cost, eliminated downtime, convenience, and painless drug delivery system further widens the opportunities for the global nasal spray market toward a wider footprint during the forecast. A growing trend of minimally invasive treatment is observed which makes the nasal spray market highly lucrative due to its functionality.

Top Market Manufacturers

The key participants in the global nasal spray market are Merck & Co., Inc., Ultratech India Limited, Novartis AG, Johnson & Johnson Services, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc., Aishwarya Group, AptarGroup, GlaxoSmithKline plc, Catalent, Inc., ADAPT Pharma, Inc., Egalet Corporation, ARIUS FORMULATIONS PVT LTD., St. Renatus, Mylan N.V., LEEFORD HEALTHCARE LTD., Aurena, Cipla Ltd, ALLERGAN, INNOVUS PHARMACEUTICALS, INC., Bayer AG, J Pharmaceuticals, and Sandoz International GmbH, among others.

Market Dynamics

Here are some noteworthy collaborations and achievements incurred by the key players in the market during the forecast –

• Pfizer collaborated with Western Oncolytics in order to advance the Western Oncalytic’ novel oncolytic vaccinia virus which helped Pfizer develops their novel technology platform for cancer vaccines as they strengthened their immune-oncology range of products.
• The FDA recently approved the use of Spravato (esketamine) nasal spray for treating adult patients suffering from treatment-resistant depression.
• Lily developed a nasal spray called intranasal glucagon which can be integrated for usage in emergency applications for patients suffering from low blood sugar disorders.

On the basis of containers, the global nasal spray market can be divided into pressurized canisters and pump bottles. The pump bottles are expected to witness the largest market share during the forecast owing to various factors such as better reliability, availability, low-cost, and portable measures.

The global nasal spray market can be segmented into allergic and non-allergic rhinitis, nose congestion, central nervous system disorders, vaccination, and others on the basis of application. The nose congestion category holds the largest share in the market due to the growing prevalence of the condition in the both the developed and developing nations.

On the basis of end-users, the global nasal spray market can be fragmented into home care settings, clinics, ambulatory surgery centers, community healthcare centers, and hospitals. The home care settings are expected to witness the largest market share during the forecast owing to less time and resources spent on the treatment and the comfort and convenience it preludes to the patient. Furthermore, the increasing patient preference for self-administering needs. The hospital category will account for significant market growth during the same period with an increase of patients suffering from chronic rhinitis being the major driver.

North America Is Expected To Hold The Largest Market Share During the Forecast Period

North America is expected to witness the largest market share during the forecast in terms of global revenue contribution. The recent trend indicates a surge of the population is prone to disorders rooting from conditions such as nasal allergies, allergic rhinitis, and structural blockages among others. This opens the door for the nasal spray market in the region to expand to a higher footprint. Increasing consumer awareness among patients coupled with the benefits associated with the sector will further propel the growth of the market.

Browse the full “Nasal Spray Market By Class (Salt-Water Solution, Decongestants, Steroid, Antihistamine, & Others), By Form (Sprays, Drops & Liquids, Powders, & Gels), By Container (Pressurized Canisters & Pump Bottles), By Patient Type (Infants, Adults, And Pediatric), By Prescription Mode (Over the Counter, Prescription Based), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, and Anticholinergic), By Dosage (Multi-Dose, Bi-Dose, & Unit-Dose), By Application (Allergic & Non-Allergic Rhinitis, Central Nervous System Disorders, Nose Congestion, Vaccination, & Others), By End-Users (Home Care Settings, Clinics, Ambulatory Surgery Centers, Community Health Care, & Hospitals), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026”  report at https://www.fnfresearch.com/nasal-spray-market

The global nasal spray market can be segmented into:

Global Nasal Spray Market: By Class Segment Analysis

• Salt-Water Solution
• Decongestants
• Steroid
• Antihistamine
• Others

Global Nasal Spray Market: By Form Segment Analysis

• Sprays
• Drops & Liquids
• Powders
• Gels

Global Nasal Spray Market: By Patient Type Segment Analysis

• Infant
• Pediatric
• Adults

Global Nasal Spray Market: By Prescription Mode Segment Analysis

• Over the Counter
• Prescription Based

Global Nasal Spray Market: By Therapeutic Class Segment Analysis

• Antihistamine
• Nasal Steroids
• Mast Cell Inhibitor
• Anticholinergic

Global Nasal Spray Market: By Container Segment Analysis

• Pressurized Canisters
• Pump Bottles

Global Nasal Spray Market: By Dosage Segment Analysis

• Multi-Dose
• Bi-Dose
• Unit-Dose

Global Nasal Spray Market: Product Application Analysis

• Allergic & Non-Allergic Rhinitis
• Nose Congestion
• Vaccination
• Central Nervous System Disorders
• Others

Global Nasal Spray Market: By End-Users Segment Analysis

• Home Care Settings
• Clinics
• Community Healthcare Settings
• Ambulatory Surgery Centers
• Hospitals

Global Nasal Spray Market: By Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of MEA

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]